| A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer (NCT00625430) | Biotech Equity Partners Pty Ltd | 2008-03-01 |
| Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions (NCT01367626) | Roxane Laboratories | 2008-03-01 |
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940 (NCT00689780) | AstraZeneca | 2008-03-01 |
| 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients (NCT00616733) | Daiichi Sankyo | 2008-03-01 |
| A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors (NCT00633958) | Dana-Farber Cancer Institute | 2008-03-01 |
| Study GSI-136 in Healthy Young and Healthy Elderly Subjects (NCT00718731) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-03-01 |
| Phase I Study of Vorinostat and Sorafenib in Advanced Cancer (NCT00635791) | University of Colorado, Denver | 2008-03-01 |
| Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib (NCT00667147) | University of Southern California | 2008-03-01 |
| Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers (NCT02173652) | Boehringer Ingelheim | 2008-03-01 |
| An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035) (NCT00635830) | Merck Sharp & Dohme LLC | 2008-03-01 |
| A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies (NCT00649584) | Seagen Inc. | 2008-03-01 |
| A Study of ARQ 197 in Healthy Volunteers to Assess the Pharmacokinetic (PK) Profile in Extensive and Poor Metabolizers as Defined by Cytochrome P450 2C19 (CYP 2C19) Genotype (NCT00651638) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2008-03-01 |
| Proellex® Pharmacokinetic Bridging Study II (NCT00620503) | Repros Therapeutics Inc. | 2008-02-29 |
| Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer (NCT00923273) | National Cancer Institute (NCI) | 2008-02-29 |
| Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04) (NCT00636558) | Viralytics | 2008-02-29 |
| A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test (NCT00763204) | Pfizer | 2008-02-29 |
| Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese Subjects (NCT00625196) | GlaxoSmithKline | 2008-02-27 |
| Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer (NCT01167530) | Gustave Roussy, Cancer Campus, Grand Paris | 2008-02-26 |
| A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. (NCT00609596) | GlaxoSmithKline | 2008-02-26 |
| A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward (NCT00605241) | GlaxoSmithKline | 2008-02-25 |
| A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001) (NCT00648648) | Merck Sharp & Dohme LLC | 2008-02-25 |
| Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood (NCT00923910) | National Cancer Institute (NCI) | 2008-02-22 |
| Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease (NCT00675090) | GlaxoSmithKline | 2008-02-21 |
| A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia (NCT01559272) | Janssen Research & Development, LLC | 2008-02-21 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002) (NCT00635804) | Merck Sharp & Dohme LLC | 2008-02-19 |
| Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074) (NCT00642954) | Merck Sharp & Dohme LLC | 2008-02-13 |
| A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC) (NCT00596648) | Exelixis | 2008-02-12 |
| A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014) (NCT01294709) | Merck Sharp & Dohme LLC | 2008-02-12 |
| Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex (NCT04008979) | PLx Pharma | 2008-02-11 |
| Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation (NCT00620633) | Memorial Sloan Kettering Cancer Center | 2008-02-08 |
| Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer (NCT01445405) | National Cancer Institute (NCI) | 2008-02-05 |
| AED/Statin Interaction Study (NCT00627575) | GlaxoSmithKline | 2008-02-04 |
| Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders (NCT00588991) | National Cancer Institute (NCI) | 2008-02-04 |
| GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study (NCT00631592) | ViiV Healthcare | 2008-02-01 |
| A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED) (NCT01021527) | Merck Sharp & Dohme LLC | 2008-02-01 |
| Dose Escalation Safety Study of MM-10-001 in Healthy Subjects (NCT00677027) | GlycaNova Norge AS | 2008-02-01 |
| Staccato Zaleplon Single Dose Pharmacokinetics (NCT00620620) | Alexza Pharmaceuticals, Inc. | 2008-02-01 |
| Rapamycin for Prevention of Chronic Graft-Versus-Host Disease (NCT00623012) | Yale University | 2008-02-01 |
| Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers (NCT00632086) | POZEN | 2008-02-01 |
| Far Infrared Treatment for Alzheimer's Disease (NCT00599469) | GAAD Medical Research Institute Inc. | 2008-02-01 |
| Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis (NCT00468208) | University of Pennsylvania | 2008-02-01 |
| Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas (NCT00613223) | Annick Desjardins | 2008-02-01 |
| Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium (NCT01090466) | Cardiff University | 2008-02-01 |
| Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion (NCT01108562) | Loma Linda University | 2008-02-01 |
| Acupuncture and Laser Acupoint Treatment on Hypertension (NCT00459680) | Logan College of Chiropractic | 2008-02-01 |
| Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin (NCT00618579) | ThromboGenics | 2008-02-01 |
| PR104 and G-CSF in Treating Patients With Solid Tumors (NCT00616213) | Proacta, Incorporated | 2008-02-01 |
| Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz (NCT00960570) | Mutual Pharmaceutical Company, Inc. | 2008-02-01 |
| Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy Volunteers (NCT00813774) | UCB Pharma | 2008-02-01 |
| Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat (NCT00791011) | Amgen | 2008-02-01 |
| A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer (NCT00568022) | R-Pharm | 2008-02-01 |
| Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients (NCT01690377) | Radboud University Medical Center | 2008-02-01 |
| Bioequivalence Study Of Verapamil (NCT00668967) | Pfizer | 2008-02-01 |
| Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema (NCT00886808) | iCo Therapeutics Inc. | 2008-02-01 |
| Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors (NCT00613145) | SCRI Development Innovations, LLC | 2008-02-01 |
| Single/Multiple Dose Bioavailability Trial (NCT00751556) | Bayer | 2008-02-01 |
| Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin (NCT00861328) | Traws Pharma, Inc. | 2008-02-01 |
| A Study to Evaluate the Effect of Far Infrared Radiation for Cancer Treatment (NCT00574106) | GAAD Medical Research Institute Inc. | 2008-02-01 |
| The Effect of Chloroquine in the Treatment of Patients With Dengue (NCT00849602) | University of Sao Paulo | 2008-02-01 |
| Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305 (NCT00689403) | AstraZeneca | 2008-02-01 |
| A Study of ARRY-334543 in Patients With Advanced Cancer (NCT00637702) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2008-02-01 |
| Vigabatrin Ph 1 Cocaine Interaction Study (NCT00626834) | National Institute on Drug Abuse (NIDA) | 2008-02-01 |
| A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide (NCT00537511) | Celgene | 2008-02-01 |
| Studies of Immune Responses to Orally Administered Vaccines in Developing Country (NCT01019083) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2008-02-01 |
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386 (NCT00690079) | AstraZeneca | 2008-02-01 |
| To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females (NCT00651534) | GlaxoSmithKline | 2008-02-01 |
| Cognitive Health Promotion Project in the Community (NCT01012947) | Ajou University School of Medicine | 2008-02-01 |
| Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554 (NCT00651027) | Pfizer | 2008-02-01 |
| Strength Training and Stroke (NCT00629005) | US Department of Veterans Affairs | 2008-02-01 |
| Green Tea and Tai Chi for Bone Health (NCT00625391) | Texas Tech University Health Sciences Center | 2008-02-01 |
| Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa (NCT00851435) | Kenta Biotech Ltd | 2008-02-01 |
| Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin (NCT00652119) | Massachusetts General Hospital | 2008-02-01 |
| A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers (NCT01714193) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-02-01 |
| Bioequivalence Study of SB797620 in Healthy Japanese Volunteers (NCT00549263) | GlaxoSmithKline | 2008-02-01 |
| Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells (NCT00562666) | Rennes University Hospital | 2008-02-01 |
| Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System (NCT00706095) | Eisai Inc. | 2008-02-01 |
| PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer (NCT00589550) | Thomas Olencki | 2008-02-01 |
| Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment (NCT00644917) | Healthpoint | 2008-02-01 |
| Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis (NCT00628797) | Nicolas Hunzelmann | 2008-02-01 |
| Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer (NCT00631527) | M.D. Anderson Cancer Center | 2008-02-01 |
| Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy (NCT00727415) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2008-02-01 |
| Study Evaluating Multiple Ascending Dose in Schizophrenia Patients (NCT00620568) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-02-01 |
| Effect of Dexamethasone on Migraine Headache (NCT00733382) | Shiraz University of Medical Sciences | 2008-02-01 |
| Far Infrared Treatment for Kidney Diseases (NCT00599391) | GAAD Medical Research Institute Inc. | 2008-02-01 |
| SD Cystic Fibrosis Study (NCT00605761) | GlaxoSmithKline | 2008-02-01 |
| Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal (NCT00638651) | University of Miami | 2008-02-01 |
| Gene Transfer for Cancer Pain (NCT00804076) | Diamyd Inc | 2008-02-01 |
| Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients (NCT00621361) | AstraZeneca | 2008-02-01 |
| Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects (NCT00627120) | VGX Pharmaceuticals, LLC | 2008-02-01 |
| Enteroaggregative E.Coli (EAEC) (NCT00362869) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-02-01 |
| Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma (NCT01042704) | Robert Redner, MD | 2008-02-01 |
| Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation (NCT00630435) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-02-01 |
| Lubiprostone Effects on Visceral Pain Sensitivity (NCT01166789) | University of North Carolina, Chapel Hill | 2008-02-01 |
| Pharmacokinetics of Bisacodyl or Sodium Picosulfate Administered Orally in Healthy Lactating Females (NCT02211911) | Boehringer Ingelheim | 2008-02-01 |
| Oral NRX 194204 in Patients With Refractory Malignancies (NCT00630760) | University of Southern California | 2008-02-01 |
| Implantation of Markers for the Radiotherapy of Lung Cancer Patients (NCT00856427) | Virginia Commonwealth University | 2008-02-01 |
| A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease (NCT00626184) | Alvine Pharmaceuticals Inc. | 2008-02-01 |
| Safety Study of Infusion of SGT-53 to Treat Solid Tumors (NCT00470613) | SynerGene Therapeutics, Inc. | 2008-02-01 |
| Abuse Potential of Sativex (NCT01323569) | Jazz Pharmaceuticals | 2008-02-01 |
| Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population (NCT00621283) | Massachusetts General Hospital | 2008-02-01 |